Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

<< Previous
Bullboard Posts
Next >>
Post by Stockfshron Jun 13, 2022 9:22pm
254 Views
Post# 34753878

Summer doldrums

Summer doldrumsI have been thinking more and more about those $0.35 and $0.30 warrants expiring in September. I think there are more of them left than some think. Many warrant holders still own at least some of the stock that gave rise to their warrants as they wait to see if news drives up the regular stock price prior to warrant expiration. The idea being that they will sell their regular shares to exercise the warrants and pocket any difference. If they start believing the stock is going to languish now through summer (perhaps due to a few items such as continued general market malaise due to fear of Fed rate hikes to fight inflation, Ukraine war, supply chain issues, fear of China/Taiwan hostilities, high gasoline prices, general summer doldrums, etc.), why would they hold on to their regular shares? They won't. They will sell now to raise cash to exercise those warrants later in September. Anything they get above the warrant exercise price is a bonus. That's a long way down from where we are trading now. Or we get taken out too cheap. Also not a palatable option.
After these two tranches of warrants are cleared away I see a more digestible scenario. Sometime in September. Although you never know what news rears its head or when, those who did not want to sell because their volume of shares might drive the price down may wish they had.

<< Previous
Bullboard Posts
Next >>